InflaRx NV (IFRX)
1.72
+0.01
(+0.58%)
USD |
NASDAQ |
Oct 02, 16:00
1.725
0.00 (0.00%)
After-Hours: 20:00
InflaRx Price to Book Value : 1.517 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.517 |
| October 01, 2026 | 1.508 |
| September 30, 2026 | 1.587 |
| September 29, 2026 | 1.631 |
| September 28, 2026 | 1.605 |
| September 25, 2026 | 1.666 |
| September 24, 2026 | 1.702 |
| September 23, 2026 | 1.728 |
| September 22, 2026 | 1.834 |
| September 21, 2026 | 1.869 |
| September 18, 2026 | 1.843 |
| September 17, 2026 | 1.816 |
| September 16, 2026 | 1.799 |
| September 15, 2026 | 1.781 |
| September 14, 2026 | 1.869 |
| September 11, 2026 | 1.843 |
| September 10, 2026 | 1.808 |
| September 09, 2026 | 1.843 |
| September 08, 2026 | 1.913 |
| September 04, 2026 | 1.958 |
| September 03, 2026 | 1.966 |
| September 02, 2026 | 2.019 |
| September 01, 2026 | 1.905 |
| August 31, 2026 | 1.878 |
| August 28, 2026 | 1.966 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.002 |
| August 26, 2026 | 2.134 |
| August 25, 2026 | 2.169 |
| August 24, 2026 | 1.808 |
| August 21, 2026 | 1.852 |
| August 20, 2026 | 1.781 |
| August 19, 2026 | 1.869 |
| August 18, 2026 | 1.922 |
| August 17, 2026 | 1.825 |
| August 14, 2026 | 1.799 |
| August 13, 2026 | 1.772 |
| August 12, 2026 | 1.772 |
| August 11, 2026 | 1.764 |
| August 10, 2026 | 1.728 |
| August 07, 2026 | 1.622 |
| August 06, 2026 | 1.517 |
| August 05, 2026 | 1.561 |
| August 04, 2026 | 1.570 |
| August 03, 2026 | 1.543 |
| July 31, 2026 | 1.499 |
| July 30, 2026 | 1.517 |
| July 29, 2026 | 1.455 |
| July 28, 2026 | 1.490 |
| July 27, 2026 | 1.499 |
| July 24, 2026 | 1.534 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| MediGene AG | -- |
| BioNTech SE | 1.199 |
| Immatics NV | 2.271 |
| Arrowhead Pharmaceuticals, Inc. | 19.46 |
| Oncolytics Biotech, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 1930.26 |
| Price | 1.72 |
| Earnings Yield | -37.70% |
| Market Cap | 253.47M |